APA (7th ed.) Citation

Liu, C., Zheng, S., Wang, S., Wang, X., Feng, X., Sun, N., & He, J. (2021). Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma. SAGE Publishing.

Chicago Style (17th ed.) Citation

Liu, Chengming, Sufei Zheng, Sihui Wang, Xinfeng Wang, Xiaoli Feng, Nan Sun, and Jie He. Development and External Validation of a Composite Immune-clinical Prognostic Model Associated with EGFR Mutation in East-Asian Patients with Lung Adenocarcinoma. SAGE Publishing, 2021.

MLA (8th ed.) Citation

Liu, Chengming, et al. Development and External Validation of a Composite Immune-clinical Prognostic Model Associated with EGFR Mutation in East-Asian Patients with Lung Adenocarcinoma. SAGE Publishing, 2021.